FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38898011000001108: Hyoscine 1mg/72hours transdermal patches (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1575021000001113 Hyoscine 1mg/72hours transdermal patches en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1575041000001115 Hyoscine 1mg/72hours transdermal patches (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hyoscine 1mg/72hours transdermal patches Is a Hyoscine (base) true Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches Is a Product containing scopolamine false Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route patch.transdermal ontology form and route true Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches Has specific active ingredient Scopolamine true Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Transdermal route true Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Scopoderm TTS 1.5mg patches (Mawdsley-Brooks & Company Ltd) Is a True Hyoscine 1mg/72hours transdermal patches Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Waymade Healthcare Plc) Is a True Hyoscine 1mg/72hours transdermal patches Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours patches 2 patch Has VMP True Hyoscine 1mg/72hours transdermal patches Inferred relationship Existential restriction modifier
Scopoderm 1.5mg patches (Pilsco Ltd) Is a True Hyoscine 1mg/72hours transdermal patches Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches 5 patch Has VMP True Hyoscine 1mg/72hours transdermal patches Inferred relationship Existential restriction modifier
Scopoderm 1.5mg patches (Baxter Healthcare Ltd) Is a True Hyoscine 1mg/72hours transdermal patches Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Novartis Consumer Health UK Ltd) Is a True Hyoscine 1mg/72hours transdermal patches Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start